Cidara Therapeutics Financial Overview
Cidara Therapeutics's market cap is currently $6.93B. The company's EPS TTM is $-3.1; its P/E ratio is ―; Cidara Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-1.57. See an overview of income statement, balance sheet, and cash flow financials.
